Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of $0.00, $0.47 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $628 million versus the consensus estimate of $616.79 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.